Abstract
Saccharomyces cerevisiae, bakers' yeast, is not a pathogen in healthy individuals, but is increasingly isolated from immunocompromised patients. The more frequent isolation of S. cerevisiae clinically raises a number of questions concerning the origin, survival, and virulence of this organism in human hosts. Here we compare the virulence of a human isolate, a strain isolated from decaying fruit, and a common laboratory strain in a mouse infection model. We find that the plant isolate is lethal in mice, whereas the laboratory strain is avirulent. A knockout of the SSD1 gene, which alters the composition and cell wall architecture of the yeast cell surface, causes both the clinical and plant isolates to be more virulent in the mouse model of infection. The hypervirulent ssd1 Delta/ssd1 Delta yeast strain is a more potent elicitor of proinflammatory cytokines from macrophages in vitro. Our data suggest that the increased virulence of the mutant strains is a consequence of unique surface characteristics that overstimulate the proinflammatory response.
MeSH Terms
Animals
Cell Wall/metabolism
Cytokines/metabolism
Enzyme-Linked Immunosorbent Assay
Glucans/chemistry
Heterozygote
Homozygote
Humans
Interleukin-1/biosynthesis
Interleukin-6/blood
Macrophages/metabolism
Mice
Mice, Inbred BALB C
Mice, Inbred DBA
Mice, Knockout
Mutation
Saccharomyces cerevisiae/genetics,pathogenicity
Shock
Temperature
Time Factors
Tumor Necrosis Factor-alpha/biosynthesis
beta-Glucans
Chemicals
Cytokines
Glucans
Interleukin-1
Interleukin-6
Tumor Necrosis Factor-alpha
beta-Glucans
beta-1,3-glucan
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Wheeler Robert T
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, MA 02139,USA.
Kupiec Martin
Magnelli Paula
Abeijon Claudia
Fink Gerald R
References (26)
26 references, click to expand
-
Bakers' yeast, a model for fungal biofilm formation.
Science. 2001 Feb 2;291(5505):878-81
PMID: 11157168
-
Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae.
Yeast. 1999 Oct;15(14):1541-53
PMID: 10514571
-
Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity.
Nat Med. 2001 May;7(5):625-9
PMID: 11329066
-
Development of Saccharomyces cerevisiae as a model pathogen. A system for the genetic identification of gene products required for survival in the mammalian host environment.
Genetics. 2001 Oct;159(2):499-513
PMID: 11606528
-
Saccharomyces cerevisiae MPT5 and SSD1 function in parallel pathways to promote cell wall integrity.
Genetics. 2002 Jan;160(1):83-95
PMID: 11805047
-
A refined method for the determination of Saccharomyces cerevisiae cell wall composition and beta-1,6-glucan fine structure.
Anal Biochem. 2002 Feb 1;301(1):136-50
PMID: 11811978
-
Innate immune recognition.
Annu Rev Immunol. 2002;20:197-216
PMID: 11861602
-
Phagocytosis of microbes: complexity in action.
Annu Rev Immunol. 2002;20:825-52
PMID: 11861619
-
Dissecting the architecture of a quantitative trait locus in yeast.
Nature. 2002 Mar 21;416(6878):326-30
PMID: 11907579
-
Seven cases of fungemia with Saccharomyces boulardii in critically ill patients.
Intensive Care Med. 2002 Jun;28(6):797-801
PMID: 12107689
-
Interactions of fungi with phagocytes.
Curr Opin Microbiol. 2002 Aug;5(4):359-65
PMID: 12160853
-
Dectin-1 is a major beta-glucan receptor on macrophages.
J Exp Med. 2002 Aug 5;196(3):407-12
PMID: 12163569
-
Genealogy of principal strains of the yeast genetic stock center.
Genetics. 1986 May;113(1):35-43
PMID: 3519363
-
The SIT4 protein phosphatase is required in late G1 for progression into S phase.
Cold Spring Harb Symp Quant Biol. 1991;56:75-81
PMID: 1668092
-
Genetic characterization of pathogenic Saccharomyces cerevisiae isolates.
Genetics. 1994 Apr;136(4):1261-9
PMID: 8013903
-
Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42 degrees C and form pseudohyphae.
Infect Immun. 1994 Dec;62(12):5447-55
PMID: 7960125
-
Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice.
Infect Immun. 1995 Feb;63(2):478-85
PMID: 7822013
-
Cell surface hydrophobicity and medically important fungi.
Curr Top Med Mycol. 1995;6:1-31
PMID: 8724239
-
Ssd1p of Saccharomyces cerevisiae associates with RNA.
J Biol Chem. 1997 Jun 27;272(26):16103-9
PMID: 9195905
-
Novel and established applications of microbial polysaccharides.
Trends Biotechnol. 1998 Jan;16(1):41-6
PMID: 9470230
-
Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications.
Yeast. 1998 Jan 30;14(2):115-32
PMID: 9483801
-
Septic shock.
Lancet. 1998 May 16;351(9114):1501-5
PMID: 9605819
-
Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).
J Clin Microbiol. 1998 Sep;36(9):2613-7
PMID: 9705402
-
The serum mannose-binding protein and the macrophage mannose receptor are pattern recognition molecules that link innate and adaptive immunity.
Semin Immunol. 1998 Oct;10(5):363-72
PMID: 9799711
-
Are live saccharomyces yeasts harmful to patients?
Lancet. 1999 May 29;353(9167):1851-2
PMID: 10359415
-
Resistance to the plant PR-5 protein osmotin in the model fungus Saccharomyces cerevisiae is mediated by the regulatory effects of SSD1 on cell wall composition.
Plant J. 2001 Feb;25(3):271-80
PMID: 11208019